Genentech, South San Francisco, CA, United States.
Front Immunol. 2019 Sep 4;10:2019. doi: 10.3389/fimmu.2019.02019. eCollection 2019.
Colony-stimulating factor 1 (CSF1) and interleukin 34 (IL34) signal the CSF1 receptor to regulate macrophage differentiation. Studies in IL34- or CSF1-deficient mice have revealed that IL34 function is limited to the central nervous system and skin during development. However, the roles of IL34 and CSF1 at homeostasis or in the context of inflammatory diseases or cancer in wild-type mice have not been clarified . By neutralizing CSF1 and/or IL34 in adult mice, we identified that they play important roles in macrophage differentiation, specifically in steady-state microglia, Langerhans cells, and kidney macrophages. In several inflammatory models, neutralization of both CSF1 and IL34 contributed to maximal disease protection. However, in a myeloid cell-rich tumor model, CSF1 but not IL34 was required for tumor-associated macrophage accumulation and immune homeostasis. Analysis of human inflammatory conditions reveals IL34 upregulation that may account for the protection requirement of IL34 blockade. Furthermore, evaluation of IL34 and CSF1 blockade treatment during infection reveals no substantial safety concerns. Thus, IL34 and CSF1 play non-redundant roles in macrophage differentiation, and therapeutic intervention targeting IL34 and/or CSF1 may provide an effective treatment in macrophage-driven immune-pathologies.
集落刺激因子 1 (CSF1) 和白细胞介素 34 (IL34) 信号通过 CSF1 受体调节巨噬细胞分化。在 IL34 或 CSF1 缺陷型小鼠中的研究表明,IL34 的功能在发育过程中仅限于中枢神经系统和皮肤。然而,在野生型小鼠中,IL34 和 CSF1 在稳态或炎症性疾病或癌症背景下的作用尚未阐明。通过在成年小鼠中中和 CSF1 和/或 IL34,我们确定它们在巨噬细胞分化中发挥重要作用,特别是在稳态小神经胶质细胞、朗格汉斯细胞和肾脏巨噬细胞中。在几种炎症模型中,中和 CSF1 和 IL34 都有助于最大程度地保护疾病。然而,在富含髓样细胞的肿瘤模型中,CSF1 而不是 IL34 对于肿瘤相关巨噬细胞的积累和免疫稳态是必需的。对人类炎症状况的分析揭示了 IL34 的上调,这可能解释了 IL34 阻断的保护需求。此外,在 感染期间评估 IL34 和 CSF1 阻断治疗没有发现实质性的安全问题。因此,IL34 和 CSF1 在巨噬细胞分化中发挥非冗余作用,针对 IL34 和/或 CSF1 的治疗干预可能为巨噬细胞驱动的免疫病理提供有效的治疗方法。